E)-N'-(substituted-benzylidene)-2-(7-fluoro-2-methoxyquinolin-8-yl) acetohydrazide-hydrazone derivatives reported in this manuscript represents a new series of antibacterial agents as well as the DNA gyrase inhibitors. Efforts were made to synthesize these quinolone-acetohydrazide-hydrazone derivatives (9a-n) in excellent yields. All the target compounds were evaluated for their in vitro antimicrobial activity against Escherichia coli (MTCC 443), Pseudomonas aeruginosa (MTCC 424) as specimens for Gram-negative bacteria, and Staphylococcus aureus (MTCC 96) and Staphylococcus pyogenes (MTCC 442) as specimens for Gram-positive bacteria. Excellent antibacterial activity was observed for compounds substituted with R=3,4,5-trimethoxy, 4-F, 4-OCF3, 4-CF3 , 3-CF3 moieties. Derivatives 9a-n were docked into the active sites of DNA gyrase A and DNA gyrase B in order to get more insight into the binding mode of the compounds. Among all derivatives, 9n showed a least binding energy as -91.6 kcal/mol was the best among all compounds for DNA gyrase A. DNA gyrase enzyme inhibtion assay favors the compound 9m and 9n, which were substituted with di-fluorine moieties (R = 2,4difluoro and 3,4-difluoro) in the quinoline scaffold, as the most potent inhibitors with of S. aureus DNA gyrase A (9mIC50 0.14 mg/mL and 9nIC50 0.19 mg/mL).